1. Transmembrane protease serine 2 (
- Author
-
Gonzalo, Villapalos-García, Pablo, Zubiaur, Rebeca, Rivas-Durán, Pilar, Campos-Norte, Cristina, Arévalo-Román, Marta, Fernández-Rico, Lucio, García-Fraile Fraile, Paula, Fernández-Campos, Paula, Soria-Chacartegui, Sara, Fernández de Córdoba-Oñate, Pablo, Delgado-Wicke, Elena, Fernández-Ruiz, Isidoro, González-Álvaro, Jesús, Sanz, Francisco, Abad-Santos, and Ignacio, de Los Santos
- Subjects
Male ,Sex Factors ,Serine Endopeptidases ,Serine ,COVID-19 ,Humans ,Female ,Comorbidity ,Severity of Illness Index - Abstract
By the end of December 2021, coronavirus disease 2019 (COVID-19) produced more than 271 million cases and 5.3 million deaths. Although vaccination is an effective strategy for pandemic control, it is not yet equally available in all countries. Therefore, identification of prognostic biomarkers remains crucial to manage COVID-19 patients. The aim of this study was to evaluate predictors of COVID-19 severity previously proposed. Clinical and demographic characteristics and 120 single-nucleotide polymorphisms were analyzed from 817 patients with COVID-19, who attended the emergency department of the Hospital Universitario de La Princesa during March and April 2020. The main outcome was a modified version of the 7-point World Health Organization (WHO) COVID-19 severity scale (WHOCS); both in the moment of the first hospital examination (WHOCS-1) and of the severest WHOCS score (WHOCS-2). The
- Published
- 2022